NEQIA Trademark

Trademark Overview


On Friday, September 14, 2012, a trademark application was filed for NEQIA with the United States Patent and Trademark Office. The USPTO has given the NEQIA trademark a serial number of 85729499. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 25, 2015. This trademark is owned by Glaxo Group Limited. The NEQIA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
neqia

General Information


Serial Number85729499
Word MarkNEQIA
Filing DateFriday, September 14, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 25, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 19, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Tuesday, May 26, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 25, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014EXTENSION 3 GRANTED
Wednesday, October 1, 2014EXTENSION 3 FILED
Wednesday, October 1, 2014TEAS EXTENSION RECEIVED
Thursday, May 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 30, 2014EXTENSION 2 GRANTED
Wednesday, April 9, 2014EXTENSION 2 FILED
Tuesday, April 29, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 9, 2014TEAS EXTENSION RECEIVED
Friday, October 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2013EXTENSION 1 GRANTED
Wednesday, October 2, 2013EXTENSION 1 FILED
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Tuesday, April 23, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 22, 2013ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 18, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 7, 2013ASSIGNED TO EXAMINER
Wednesday, September 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 18, 2012NEW APPLICATION ENTERED IN TRAM